Eleven Therapeutics
PrivateLast Round
Seed
Aug 2, 2022
Total Funding Raised
$22.4M
Company Overview
Eleven Therapeutics is a biotechnology company that develops RNAi therapeutics by combining artificial intelligence, massively parallel functional assays, and combinatorial chemistry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eleven Therapeutics Comparables
Compare Eleven Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therna Biosciences | 83% | |
| Shape Therapeutics | 82% | |
| Sail Biomedicines | 78% | |
Eleven Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 2, 2022 | ||||
| Grant | Dec 18, 2021 |
Key People
Founding team and executive leadership
Eleven Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed, Grant |
| NFX | Seed |
| Entrée Capital | Seed |
| Gates Foundation | Seed |
| Harel Insurance Investments & Financial Services | Seed |
| Innovate UK | Grant |
| Entrée Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2022
$22M round led by Gates Foundation
- Dec 18, 2021
$400K raised from Innovate UK.
Eleven Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eleven Therapeutics's valuation, stock price, and market status.